ArticleBMC pharmacology & toxicology2022

Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study.

Jimyung Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.